A soluble LAG-3 protein (eftilagimod alpha) and an anti-PD-L1 antibody (avelumab) tested in a phase I trial: a new combination in immuno-oncology - Concepedia

Concepedia

Publication | Open Access

A soluble LAG-3 protein (eftilagimod alpha) and an anti-PD-L1 antibody (avelumab) tested in a phase I trial: a new combination in immuno-oncology

DOI Full Paper Access

10

Citations

33

References

2023

Year

S-E. Al-Batran, Daniel Mueller, M.-R. Rafiyan, Dragan Kiselicki, Akin Atmaca, Timorshah Habibzada, Christian Mueller, Chrystelle Brignone, Frédéric Triebel, Maria Loose,

References

	Year	Citations

Page 1